Search - tctmd.com

Displaying 241 - 260 of 268

Sort: Relevancy | Date

News Daily News

El Ticagrelor ofrece una Inhibición Plaquetaria Más Potente que el Prasugrel

July 10, 2012

Presentation

Ticagrelor vs. Prasugrel in ACS Patients with High On-Clopidogrel Platelet Reactivity Following PCI

Presenter: Dimitrios Alexopoulos

July 09, 2012

News Daily News

Subanálisis del PLATO: El Ticagrelor es Rentable en Pacientes con SCA

June 26, 2012

News Daily News

PLATO Subanalysis: Ticagrelor Cost-Effective in ACS Patients

June 26, 2012

News Daily News

La Opción Antitrombótica durante una PCI Influye en los Resultados de los Malos Respondedores al Clopidogrel

Caitlin E. Cox

June 07, 2012

News Daily News

Antithrombotic Choice During PCI Influences Outcomes in Poor Clopidogrel Responders

Caitlin E. Cox

June 07, 2012

News Daily News

Subestudio PLATO: Los Pacientes con SCA y Antecedentes de ACV no están en Desventaja con el Ticagrelor

Yael L. Maxwell

June 01, 2012

News Daily News

PLATO Substudy: ACS Patients with Prior Stroke at No Disadvantage with Ticagrelor

Yael L. Maxwell

June 01, 2012

News Conference News ACC 2012

ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released

Yael L. Maxwell

April 02, 2012

News Daily News

Un Registro Confirma que en el ‘Mundo Real’ la Bivalirudina es Mejor contra el STEMI

March 07, 2012

News Daily News

Registry Confirms Bivalirudin Better for STEMI in ‘Real World’

March 07, 2012

Presentation TCT 2012

Comparison of bivalirudin versus heparin during PCI in patients receiving prasugrel M Hamon, S Marso, SV Rao, M Valgimigli, F Verheugt, A Gershlick, Y Wang, GP Steg, E...

Presenter: Martial Hamon

January 03, 2012

News Conference News

Prasugrel Bests Double Clopidogrel Dose for STEMI Patients with High Residual Platelet Reactivity

November 17, 2011

News Conference News

AIDA STEMI: No Advantage for Intracoronary vs. Intravenous Abciximab

November 13, 2011

News Daily News

Thrombolysis with Immediate Transfer for PCI Safe for Rural STEMI Patients

November 02, 2011

News Daily News

First-Year Stent Thombosis Risk High—and Dangerous—in ACS Patients

October 31, 2011

News Daily News

Bivalirudin Decreases Bleeding Regardless of Heparin Anticoagulation Level

Yael L. Maxwell

October 13, 2011

News Daily News

Double-Dose Clopidogrel Reduces Infarct Size in STEMI Patients

Jason Kahn

September 26, 2011

News Daily News

Excess Dyspnea with Ticagrelor Does Not Compromise Mortality Benefit

August 03, 2011

News Daily News

Apixaban Increases Major Bleeding in High-Risk ACS Patients

Jason Kahn

July 25, 2011

Advertisement

El Ticagrelor ofrece una Inhibición Plaquetaria Más Potente que el Prasugrel

Ticagrelor vs. Prasugrel in ACS Patients with High On-Clopidogrel Platelet Reactivity Following PCI

Subanálisis del PLATO: El Ticagrelor es Rentable en Pacientes con SCA

PLATO Subanalysis: Ticagrelor Cost-Effective in ACS Patients

La Opción Antitrombótica durante una PCI Influye en los Resultados de los Malos Respondedores al Clopidogrel

Antithrombotic Choice During PCI Influences Outcomes in Poor Clopidogrel Responders

Subestudio PLATO: Los Pacientes con SCA y Antecedentes de ACV no están en Desventaja con el Ticagrelor

PLATO Substudy: ACS Patients with Prior Stroke at No Disadvantage with Ticagrelor

ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released

Un Registro Confirma que en el ‘Mundo Real’ la Bivalirudina es Mejor contra el STEMI

Registry Confirms Bivalirudin Better for STEMI in ‘Real World’

Comparison of bivalirudin versus heparin during PCI in patients receiving prasugrel M Hamon, S Marso, SV Rao, M Valgimigli, F Verheugt, A Gershlick, Y Wang, GP Steg, E...

Prasugrel Bests Double Clopidogrel Dose for STEMI Patients with High Residual Platelet Reactivity

AIDA STEMI: No Advantage for Intracoronary vs. Intravenous Abciximab

Thrombolysis with Immediate Transfer for PCI Safe for Rural STEMI Patients

First-Year Stent Thombosis Risk High—and Dangerous—in ACS Patients

Bivalirudin Decreases Bleeding Regardless of Heparin Anticoagulation Level

Double-Dose Clopidogrel Reduces Infarct Size in STEMI Patients

Excess Dyspnea with Ticagrelor Does Not Compromise Mortality Benefit

Apixaban Increases Major Bleeding in High-Risk ACS Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content